20/20 Biolabs, Inc. (AIDX) Live Share Price, Invest From India

20/20 Biolabs, Inc. Stock Performance

as on September 2, 2026 at 2:15 pm IST

Day's Low
$0.60
Day's Price Range
$0.62
$0.62
3.23%
Downside
52 Week's Low
52 Week's High
52-Week Price Range
$0.62
100.00%
Downside
-100.00%
Upside

20/20 Biolabs, Inc. share price movements today

Previous Close: $0.62
Open: $0.62
Volume: 352.7K
Market Cap: $7.9M
Day's Low - High: $0.60 - $0.62

20/20 Biolabs, Inc. Historical Returns

1 Month Return: + 44.8 %
3 Month Return: -35.21 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

20/20 Biolabs, Inc. Stock Fundamentals & Key Indicators

Check 20/20 Biolabs, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$7.9M

EPS (TTM)

-0.67

Dividend Yield

0.00%

PE Ratio (TTM)

-0.63

Industry PE ratio

-1.4408823529411765

PEG Ratio

0.0066044596231439965

Return On Equity TTM

176.20%

20/20 Biolabs, Inc. Stock Valuation

Track how 20/20 Biolabs, Inc. P/E has moved over time to understand its valuation trends.

20/20 Biolabs, Inc. in the last 5 years

Overview
Trends

Lowest (-39.75x)

March 31, 2026

Today (-39.75x)

March 31, 2026

Industry (-1.44x)

March 31, 2026

Highest (54.44x)

December 31, 2021

LowHigh

Today’s Price to Earnings Ratio: -39.75x

20/20 Biolabs, Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of 20/20 Biolabs, Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
20/20 Biolabs, Inc.	NA	$7.9M	NA	-0.63	31.52%	NA
Edwards Lifesciences	BUY	$52.3B	-24.77%	53.2	77.98%	NA
Medtronic	BUY	$116.0B	-31.69%	24.15	65.02%	3.15%
Stryker	BUY	$124.2B	14.3%	32.62	65.17%	1.0999999999999999%
Abbott Laboratories	BUY	$201.9B	-15.22%	35.71	11.65%	213.54999999999998%

See all

Indian Investors' Interest in 20/20 Biolabs, Inc. Stock

Search interest for 20/20 Biolabs, Inc. Stock has increased by 29% in the last 30 days, reflecting an upward trend in search activity.

Time period: August 3, 2026 to September 2, 2026

Change:29% versus previous 30 day period

20/20 Biolabs, Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Dec 2024	Mar 2026	Jun 2026
Total Revenue	0	0	0	0	0
Gross Profit	0	0	0	0	0
Operating Income	-1	-1	-1	-1	-1
EBITDA	-1	-1	-1	-1	-1
Interest Expense	0	0	-	0	0
Depreciation	0	0	0	0	0
Income Before Tax	-1	-1	-1	-2	-1
Income Tax Expense	-	-	-	-	-
Net Income	-1	-1	-1	-2	-1
Net Profit Margin	0.44%	11.64%	30.41%	17.80%	41.71%

20/20 Biolabs, Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Mar 2026
Total Revenue	0	0	0	2	9	11	1	1	2
Gross Profit	0	0	0	0	4	5	0	0	0
Operating Income	-1	-1	-2	-2	1	1	-6	-5	-3
EBITDA	-1	-1	-2	-1	2	1	-6	-5	-3
Interest Expense	-	-	-	-	0	0	0	0	0
Depreciation	0	0	0	0	0	0	0	0	0
Income Before Tax	-1	-1	-2	-2	2	2	-6	-5	-3
Income Tax Expense	-	-	-	-	-	-	-	-	-
Net Income	-1	-1	-2	-2	2	2	-6	-5	-3
Net Profit Margin	41.80%	21.46%	8.46%	37.64%	48.79%	46.31%	7.66%	20.56%	29.56%

20/20 Biolabs, Inc. Quarterly Cash Flow

All numbers in Millions USD

	Mar 2023	Jun 2023	Dec 2024	Mar 2026	Jun 2026
Net Income	-1	-1	-1	-2	-1
Operating Cash Flow	-1	-1	0	-1	0
Investing Cash Flow	0	0	-	0	0
Financing Cash Flow	0	0	0	4	0
Change in Cash	7	-1	0	3	0

20/20 Biolabs, Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Mar 2026
Net Income	-1	-1	-2	-2	2	2	-6	-5	-3,738
Operating Cash Flow	-1	-1	-2	-2	-1	5	-4	-2	-1,919
Investing Cash Flow	0	0	-1	1	0	0	0	-	-
Financing Cash Flow	1	3	1	3	1	0	0	0	1,161
Change in Cash	0	2	-2	2	0	5	-4	-2	-758

Global Institutional Holdings in 20/20 Biolabs, Inc.

Funds	Holdings
Vanguard	0.19%

Insights on 20/20 Biolabs, Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 7 days, AIDX stock has moved up by 9.3%

About 20/20 Biolabs, Inc.

20/20 Biolabs, Inc. develops and commercializes AI-powered, laboratory-based blood tests for the early detection and prevention of cancers and chronic diseases. It provides OneTest for Cancer, a multi-cancer early detection, or MCED and OneTest for Longevity, which measures inflammatory biomarkers. It also operates the Clinical Lab Innovation Axcelerator (CLIAx), a CLIA laboratory for overseas diagnostics start-ups. The company was formerly known as 20/20 GeneSystems, Inc. and changed its name to 20/20 Biolabs, Inc. in March 2025. The company was incorporated in 2000 and is based in Gaithersburg, Maryland.

Organisation	20/20 Biolabs, Inc.
Headquarters	15810 Gaither Road, Gaithersburg, MD, United States, 20877
Industry	Medical Devices
CEO	Mr. Jonathan Cohen
E-voting on shares	Click here to vote

Key Management of 20/20 Biolabs, Inc.

Name	Title
Dr. Jiming Zhou Ph.D.	Chief Operating Officer
Dr. Michael Saul Lebowitz Ph.D.	Chief Scientific Officer
Mr. Alan B. Bergman	Chief Financial Officer
Mr. David Lees	Director of Sales
Mr. Ronald R. Baker	Chief Business Officer
Marc Gordon	Controller
Mr. Jonathan Cohen	Founder, CEO, President & Director

FAQs

What is 20/20 Biolabs, Inc. share price today?

20/20 Biolabs, Inc. share price today is $0.62 as on September 2, 2026 at 8:45 am IST at the close of the market. 20/20 Biolabs, Inc. share today touched a day high of $0.62 and a low of $0.60.

What is the 52 week high and 52 week low for 20/20 Biolabs, Inc. share?

20/20 Biolabs, Inc. share touched a 52 week high of $0.00 on January 1, 1970 and a 52 week low of $0.00 on January 1, 1970. 20/20 Biolabs, Inc. stock price today i.e. September 2, 2026 at 8:45 am IST is closed at $0.62,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

What is 20/20 Biolabs, Inc.'s market capitalisation today?

20/20 Biolabs, Inc. market capitalisation is $0.00T as on September 2, 2026 at 8:45 am IST.

How to invest in 20/20 Biolabs, Inc. Stock (AIDX) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for 20/20 Biolabs, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in 20/20 Biolabs, Inc. Shares that will get you 2.4194 shares as per 20/20 Biolabs, Inc. share price of $0.62 per share as on September 2, 2026 at 8:45 am IST.

What is the minimum amount required to buy 20/20 Biolabs, Inc. Stock (AIDX) from India?

Indian investors can start investing in 20/20 Biolabs, Inc. (AIDX) shares with as little as ₹94.96 or $1 (as of September 2, 2026 at 6:51 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹949.60 in 20/20 Biolabs, Inc. stock (as per the Rupee-Dollar exchange rate as on September 2, 2026 at 6:51 pm IST). Based on 20/20 Biolabs, Inc. share’s latest price of $0.62 as on September 2, 2026 at 8:45 am IST, you will get 16.1290 shares of 20/20 Biolabs, Inc.. Learn more about fractional shares .